GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Albert Labs International Corp (XCNQ:ABRT) » Definitions » Debt-to-Revenue

Albert Labs International (XCNQ:ABRT) Debt-to-Revenue : N/A (As of Sep. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Albert Labs International Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Albert Labs International's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was C$0.00 Mil. Albert Labs International's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was C$0.01 Mil. Albert Labs International's annualized Revenue for the quarter that ended in Sep. 2023 was C$0.00 Mil.


Albert Labs International Debt-to-Revenue Historical Data

The historical data trend for Albert Labs International's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Albert Labs International Debt-to-Revenue Chart

Albert Labs International Annual Data
Trend Dec21 Dec22
Debt-to-Revenue
N/A N/A

Albert Labs International Quarterly Data
Mar21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only N/A N/A N/A N/A N/A

Competitive Comparison of Albert Labs International's Debt-to-Revenue

For the Biotechnology subindustry, Albert Labs International's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Albert Labs International's Debt-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Albert Labs International's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Albert Labs International's Debt-to-Revenue falls into.



Albert Labs International Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Albert Labs International's Debt-to-Revenue for the fiscal year that ended in Dec. 2022 is calculated as

Albert Labs International's annualized Debt-to-Revenue for the quarter that ended in Sep. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Sep. 2023) Revenue data.


Albert Labs International Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Albert Labs International's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Albert Labs International (XCNQ:ABRT) Business Description

Traded in Other Exchanges
N/A
Address
6996, Merritt Avenue, Burnaby, BC, CAN, V5J 4R6
Albert Labs International Corp is a laboratory-based, clinical research and drug development enterprise addressing mental health care needs. The company is focusing on Real World Evidence (RWE) the company will initially look to commercialize its mycelium-based KRN-101 medicine and treatment with the help of clinical pathway.

Albert Labs International (XCNQ:ABRT) Headlines

No Headlines